|
|
|
Volumn 16, Issue 6 Suppl 6, 2002, Pages 53-62
|
|
Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOCETAXEL;
DRUG DERIVATIVE;
PACLITAXEL;
TAXOID;
CANCER STAGING;
CLINICAL TRIAL;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
PATHOLOGY;
QUALITY OF LIFE;
REVIEW;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
HUMANS;
LUNG NEOPLASMS;
NEOPLASM STAGING;
PACLITAXEL;
QUALITY OF LIFE;
TAXOIDS;
|
|
EID: 0036616670
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (53)
|
